HSPA9 and cancer: HSPA9 not only modulates the Raf/MEK/ERK signaling pathway but also promotes the PP1α-MER1/2 interaction to increase MEK1/2 dephosphorylation in KRAS and BRAF mutant cancer cells [100, 101].